Updated Securities Trading Policy
Released
Released
Announcement PDF
JLL
JNDAF
Revised Securities Trading Policy
9 August 2024
In accordance with ASX Listing Rule 12.10, Jindalee Lithium Limited (Jindalee, the Company) lodges the
attached revised policy for Trading in Company Securities (Trading Policy).
A copy of the Trading Policy is available in the corporate governance section of the Company’s website at
www.jindaleelithium.com.
This announcement is authorised for release by the Jindalee Board of Directors.
For further information please contact:
LINDSAY DUDFIELD
Executive Director
+ 61 8 9321 7550
T:
E:
enquiry@jindalee.net
Jindalee Lithium Limited
ABN 52 064 121 133
Level 2, 9 Havelock Street, West Perth, WA, 6005
PO Box 1033, West Perth, WA 6872
IAN RODGER
Chief Executive Officer
T:
+ 61 8 9321 7550
E:
enquiry@jindalee.net
www.jindaleelithum.com
E: enquiry@jindalee.net
P: +61 9321 7550
F: +61 9321 7950
Visit Jindalee’s interactive
Investor Hub
https://investorhub.jindaleelithium.com/welcome
Policy: P004
SECURITIES TRADING POLICY
JINDALEE LITHIUM LIMITED
SECURITIES TRADING POLICY
Introduction
Jindalee Lithium Limited (Company) wishes to ensure that its stakeholders have confidence in the
trading activities of directors, officers and employees in respect of the Company’s securities.
This Securities Trading Policy (Policy) regulates dealings by directors, officers and employees of the
Company and its subsidiaries (referred to in this Policy as Representatives) in securities issued by the
Company and in certain circumstances, this Policy also applies to contractors, consultants and advisors.
The Company acknowledges that from time to time, Representatives may hold securities in the Company
and that most investors are encouraged by these holdings. It is the responsibility of the individual
Representative to ensure that any trading of the Company’s securities by them complies with the
Corporations Act 2001 (Cth), the Australian Securities Exchange (ASX) Listing Rules, OTC Markets Group
Inc Rules for International Companies and this Policy.
The Insider Trading Provision
Insider trading is a serious criminal offence. It may also result in civil liability.
In broad terms, a person will be guilty of insider trading if that person possesses information which is
not generally available to the market and, if it were generally available to the market, would be likely to
have a material effect on the price or value of the Company’s securities (eg. information that is price
sensitive) and that person:
(a)
buys or sells securities in the Company; or
(c)
communicates the information to a third party where that person knows, or ought reasonably to
know, that the third party would be likely to buy or sell the securities or procure someone else to
buy or sell the securities of the Company.
(b)
procures another person (eg. a family member, friend or family company, superannuation fund or
trust) to buy or sell securities in the Company; or
It does not matter how or where the person obtains the information – it does not have to be obtained
from the Company to constitute inside information.
A person does not need to be a director, officer, employee, contractor or consultant of the Company to
be guilty of insider trading in relation to securities in the Company. The prohibition extends to dealings
through nominees, agents or other associates, such as family members, family trusts and family
companies (referred to as Associates).
Examples of Inside Information
By way of guidance, to illustrate the prohibition described above, the following are possible examples
of price sensitive information which, if made available to the market, may be likely to materially affect
the price of the Company’s securities:
2
•
•
•
•
•
•
the Company is considering an acquisition, expansion or disposal of an interest in a major project;
significant discoveries, exploration results or changes in reserve/resource estimates from mining
tenements in which the Company has an interest;
the threat of major litigation by or against the Company;
changes to the Board, management or auditors;
the Company’s financial results materially exceeding (or falling short of) market expectation; and
a share issue proposal.
This Policy does not contain an exhaustive analysis of the restrictions imposed on and the very serious
ramifications of insider trading. Representatives who wish to obtain further advice on this matter are
encouraged to contact the Company Secretary.
Dealing in the Securities of Other Companies
Representatives must not deal in securities of other companies if they possess “inside information” or
price sensitive information in relation to the relevant company.
This restriction also extends to Company interests held in joint ventures and any trading in the securities
of joint venture partners where there is awareness of non-public information.
Guidelines for Trading in the Company’s Securities
Unless otherwise provided in this Policy, a Representative must not buy or sell Company securities in
the following periods (Closed Periods):
a)
b)
for at least one (1) trading day after any material announcement to the ASX;
for at least two (2) weeks prior to and one (1) trading day after the following events:
•
•
c)
the release of the Company’s quarterly, half year and annual financial results to the ASX;
the Annual General Meeting and all other General Meetings; or
any other period in which it is determined by the Board that there is in existence price sensitive
information that has not been disclosed because the Company is relying on an exception to ASX
Listing Rule 3.1 (continuous disclosure).
The Company may at its discretion vary this rule in relation to a particular period by general
announcement to all employees either before or during the period.
In addition, if a Representative, consultant or contractor is in possession of price sensitive information
which is not generally available to the market, then he or she must not deal in the Company’s securities
at any time.
Additional Trading restrictions for Directors and Some Employees
Additional restrictions on trading in the Company’s securities apply to Directors of the Company, all
executives reporting directly to the Managing Director (or equivalent) and any other employees,
consultants or advisors of the Company considered appropriate by the Managing Director (or
equivalent) and Company Secretary from time to time (Restricted Persons).
3
Restricted Persons generally hold positions where it can be assumed that they will have inside
information regarding the Company. Accordingly, additional requirements apply for any proposed
trading in shares by Restricted Persons.
Written Consent
If Representatives propose to deal in the Company’s Securities (which includes entering into an
agreement to deal) they must first:
(a)
(b)
complete and forward a “Notification Form to Deal in the Company’s Securities” in the form of
Part A of Schedule 1 to the “Notification Officer(s)” (as defined in Schedule 2); and
receive confirmation in the form of Part B of Schedule 1 signed by the Notification Officer(s) in
their discretion to allow them to deal in the Company’s Securities.
Notification of any dealing in the Company’s Securities under this paragraph and the completion of Part
B of the Notification Form to Deal in the Company’s Securities does not constitute approval of the dealing
by or on behalf of the Company.
Copies of written approvals must be forwarded to the Company Secretary prior to the approved
purchase or sale transaction proceeding.
Confirmation
In addition to obtaining written consent to deal in the Company’s securities, Representatives must
confirm via written or email notice to the relevant Notification Officer(s) and the Company Secretary
when the dealing in the Company’s securities is completed.
Exceptional Circumstances
The Board may waive any or all of the requirements of the Securities Trading Policy to allow trading
during a Closed Period where:
•
•
•
•
the sale of the Company’s securities is necessary to alleviate severe personal hardship.
the Representative has entered into a binding commitment prior to the Company being in a Closed
Period where it was not reasonably foreseeable at the time the commitment was made that a
Closed Period was likely.
the Representative is required by a court order, or there are court enforceable undertakings to
transfer or sell the securities of the Company or there is some other overriding legal or regulatory
requirement for him or her to do so.
there are other circumstances which have not been identified in this Policy, that are deemed
exceptional by the Board, and the proposed sale or disposal of the relevant securities is the only
reasonable course of action available.
Representatives who apply for a waiver under exceptional circumstances must obtain written consent
in accordance with this Policy prior to trading in the Company’s securities.
Trading not Subject to the Securities Trading Policy
The following is excluded from the operation of this Securities Trading Policy:
4
•
•
•
•
•
•
•
transfers of Company Securities between a Representative and their spouse, child, step-child,
family company, family trust or superannuation scheme in which the Representative is a
beneficiary.
an investment in, or trading in units of, a fund or other scheme (other than a scheme only investing
in the securities of the Company) where the assets of the fund or other scheme are invested at the
discretion of a third party.
where a Representative is a trustee, trading in the securities of the Company by that trust provided
that the Restricted Person is not a beneficiary of the trust and any decision to trade during a Closed
Period is taken by the other trustees or by the investment managers independently of the
Representative.
undertakings to accept, or the acceptance of a takeover offer.
trading under an offer or invitation made to all or substantially all of the security holders, such as
a rights issue, a security purchase plan, a dividend or distribution reinvestment plan and an equal
access buy back, where the plan that determines the timing and structure of the offer have been
approved by the Board. This includes decisions relating to whether or not to take up the
entitlements and the sale of entitlements required to provide for the take up of the balance of
entitlements under a renounceable pro rata issue.
trading through participation in a share placement or other dealings approved by shareholders at
a general meeting.
the exercise (but not the sale of securities following exercise) of an option or a right under an
employee incentive scheme, or the conversion of a convertible security, where the final date for
the exercise of the option or right, or the conversion of the security, falls during a Closed Period
and the Company has been in an exceptionally long Closed Period or the Company has had a
number of consecutive Closed Periods and the Restricted Person could not reasonably have been
expected to exercise it at a time when free to do so.
Ultimate discretion rests with the Chair of the Board in respect to granting a waiver to the requirements
of this Securities Trading Policy to allow Representatives to trade in the shares of the Company,
provided to do so would not be illegal.
Financial Arrangements
Directors and employees of the Company are prohibited from entering into financial arrangements such
as margin loans, stock lending or any other arrangements involving equity of the Company where the
lender or other third party is granted a right to sell, or compel the sale of, all or part of the Director or
employee’s securities held in the Company.
ASX Notification for Directors
Directors must notify the Company Secretary of any dealings in the Company’s securities immediately
when any such dealings occur. The Directors appoint the Company as their agent for the purposes of
compliance with the disclosure requirements on Directors’ share trading contained in ASX Listing Rule
3.19. Directors shall be responsible for providing information to the Company Secretary in order for
him/her to ensure compliance with the Listing Rules.
If the Director engaged in trading during a Closed Period, the Director must confirm to the Company
Secretary that written clearance to trade was provided by the Board, and the date on which this
clearance was provided.
General
5
Representatives should comply with the spirit and intent of this Policy. Compliance with this Policy
does not absolve that individual from complying with the law, which must be the overriding
consideration when trading in the Company’s securities.
Breach of the insider trading prohibition could expose individuals to criminal and civil liability. Breach
of the insider trading laws or this Policy will be regarded as serious misconduct which may lead to
disciplinary action and/or dismissal.
If there is any doubt as to the application of this Policy or in the case of suspected violation of this Policy,
the matter should be referred to the Company Secretary. Senior Executives and Directors should contact
the Chair.
Policy Review
This Policy will be reviewed annually.
Reference Documentation
Schedule 1 – Notification form to Deal in the Company’s Securities
Schedule 2 – Notification Officers
6
SECURITIES TRADING POLICY
SCHEDULE 1 - NOTIFICATION FORM TO DEAL IN THE COMPANY’S SECURITIES
Part A – For completion by Representative
I, …………………………………………………….., request written clearance to trade in the securities of the
Company in accordance with the terms of the Company’s Securities Trading Policy (Policy) and
provide the following information:
Name of Registered Holder:
Number of Securities:
Class of Securities:
Nature of agreement/dealing:
(sale/purchase/subscription)
Proposed date of transaction:
(ie. order date)
I confirm that:
•
I have read and understood the Securities Trading Policy (Policy) and that the proposed trading
does not breach the Policy or any legal obligations referred to therein, and in particular that I am
not in possession of any unpublished information in relation to the Company which, if generally
available, might materially affect the price or value of the Company’s securities.
•
I acknowledge that in accordance with the Policy, I cannot trade in the Company’s securities until
clearance is given and I understand that any clearance given will be valid only for the period stated
in the clearance.
•
I understand that approval under the Policy (if given) will not be an endorsement of the above
dealing, and that I remain individually responsible for complying with any applicable laws and the
Policy.
•
Where the request to trade involves the consideration of exceptional circumstances, I have
appended details of the particulars of those exception circumstances to this trading request.
Signed:
7
____________________________
Dated:
______________
Part B – For completion by Notification Officer
I confirm that the Representative may deal in the Company’s securities in accordance with the terms
set out in Part A of the schedule.
Clearance authorised by:
___________________________________
Name of Notification Officer(s)
__________________________________
Signature of Notification Officer(s)
Clearance valid for: ___________ business days from the date of clearance.
8
_________
Date
SECURITIES TRADING POLICY
SCHEDULE 2 – NOTIFICATION OFFICERS
In this policy, the relevant Notification Officer(s) for each of the Representatives is set out in
the table below:
Representative
Notification Officer(s)
Chair
Any two Directors or a Director and the Company Secretary
Executive Directors or
Chief Executive Officer
Chair or a Director and the Company Secretary
Company Secretary
Chair or any two Directors
Non-Executive Directors
All other Representatives
9
Chair or a Director and the Company Secretary
Managing Director (or equivalent), or the Company
Secretary
Share your feedback
Discover